A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.
PepGen, a UK-based developed of therapies for Duchenne muscular dystrophy spun out of University of Oxford, has raised $108m in its initial public offering on Nasdaq. The company had raised some $163m in equity funding prior to its flotation from investors including university venture fund Oxford Science Enterprises.
Quentic, a Germany-based environmental, social and governance management platform spun out of University of Applied Sciences Berlin, has been acquired by AMCS. Financial terms were not disclosed, but Quentic investor High-Tech…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
